Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of a Wide Spectrum Nutritional Supplement on Mitochondrial Function in Children With ASD
NCT03835117Phase 2Completed
- Sponsor
- Rossignol Medical Center
- Start
- Feb 2020
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Rossignol Medical Center. Primary endpoints: Change in Mitochondrial Activity: Citrate Synthase at Week 24, Change in Mitochondrial Activity: Complex I at Week 24 and 2 more. Started Feb 2020; status: completed.
02
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03835117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03835117.